https://www.selleckchem.com/pr....oducts/filanesib.htm
https://www.selleckchem.com/pr....oducts/filanesib.htm
Recognition of Genetics Whoever Appearance Report Is assigned to Non-Progression toward Supports Utilizing eQTLs. 85; 95% confidence interval [CI] 2.17-3.75; p 0.00001), and further subgroup analysis strengthened the outcome, with minor heterogeneity in non-Asian countries. In contrast, the early mortality was not significantly different between the PNH+ and PNH- groups (OR 0.54; 95% CI 0.26-1.10; p = 0.09). The meta-analysis suggested an evidence-based role for PNH clones
Like
Comment
Share
